Vitamins K1 and K2 potentiate hyperthermia by down-regulating Hsp72 expression in vitro and in vivo

Shuji Shimohara, Toru Murakami, Mari Morikawa, Junko Matsuo, Shin Ichi Nagayama, Tsuyoshi Shuto, Mary Ann Suico, Tsukasa Okiyoneda, Isao Yamatsu, Toru Mizushima, Tatsuya Shimasaki, Hirofumi Kai

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Hyperthermia is used to treat various malignancies, including esophageal, stomach and rectal cancer. Since hyperthermia alone has produced limited results, much attention has been focused on combining hyperthermia with chemotherapy and on searching for substances able to sensitize tumor cells to hyperthermia-induced damage. Here, we show that vitamins K1 and K2 (VK1, VK2) inhibited the expression of heat-shock protein 72 (Hsp72) but did not affect the constitutive expression of Hsc70 or calnexin in vitro and in vivo. VK, and VK2 sensitized A549 cells to heat-shock induced cell death, while the compounds alone had no effect on cell viability. The suppression of Hsp72 was apparently at the protein level because the mRNA expression of Hsp72 was unchanged. Moreover, the chaperone activity of Hsp72 was compromised after heat-shock when cells were pre-treated with VK 2. The effect of VK2 on Hsp72 suppression, however, was also observed in normal mouse tissue after the mice were subjected to whole-body hyperthermia. To eliminate this side effect, local hyperthermia was performed on tumors in mice. The pre-treatment with VK2 potentiated the effect of local hyperthermia on tumor growth suppression. The findings here that VK1 and VK2 inhibit heat-shock-induced Hsp72 suggest their possible use as an adjuvant for hyperthermia in cancer therapy.

Original languageEnglish
Pages (from-to)1527-1533
Number of pages7
JournalInternational Journal of Oncology
Volume27
Issue number6
Publication statusPublished - 2005 Dec
Externally publishedYes

Fingerprint

HSP72 Heat-Shock Proteins
Vitamin K 1
Vitamin K 2
Fever
Induced Hyperthermia
Shock
Hot Temperature
Neoplasms
Calnexin
Esophageal Neoplasms
Rectal Neoplasms
Stomach Neoplasms
In Vitro Techniques
Cell Survival
Cell Death
Drug Therapy
Messenger RNA
Therapeutics
Growth

Keywords

  • Heat shock
  • Hsp72
  • Hyperthermia
  • Tumor cells
  • Vitamin K

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Shimohara, S., Murakami, T., Morikawa, M., Matsuo, J., Nagayama, S. I., Shuto, T., ... Kai, H. (2005). Vitamins K1 and K2 potentiate hyperthermia by down-regulating Hsp72 expression in vitro and in vivo. International Journal of Oncology, 27(6), 1527-1533.

Vitamins K1 and K2 potentiate hyperthermia by down-regulating Hsp72 expression in vitro and in vivo. / Shimohara, Shuji; Murakami, Toru; Morikawa, Mari; Matsuo, Junko; Nagayama, Shin Ichi; Shuto, Tsuyoshi; Suico, Mary Ann; Okiyoneda, Tsukasa; Yamatsu, Isao; Mizushima, Toru; Shimasaki, Tatsuya; Kai, Hirofumi.

In: International Journal of Oncology, Vol. 27, No. 6, 12.2005, p. 1527-1533.

Research output: Contribution to journalArticle

Shimohara, S, Murakami, T, Morikawa, M, Matsuo, J, Nagayama, SI, Shuto, T, Suico, MA, Okiyoneda, T, Yamatsu, I, Mizushima, T, Shimasaki, T & Kai, H 2005, 'Vitamins K1 and K2 potentiate hyperthermia by down-regulating Hsp72 expression in vitro and in vivo', International Journal of Oncology, vol. 27, no. 6, pp. 1527-1533.
Shimohara S, Murakami T, Morikawa M, Matsuo J, Nagayama SI, Shuto T et al. Vitamins K1 and K2 potentiate hyperthermia by down-regulating Hsp72 expression in vitro and in vivo. International Journal of Oncology. 2005 Dec;27(6):1527-1533.
Shimohara, Shuji ; Murakami, Toru ; Morikawa, Mari ; Matsuo, Junko ; Nagayama, Shin Ichi ; Shuto, Tsuyoshi ; Suico, Mary Ann ; Okiyoneda, Tsukasa ; Yamatsu, Isao ; Mizushima, Toru ; Shimasaki, Tatsuya ; Kai, Hirofumi. / Vitamins K1 and K2 potentiate hyperthermia by down-regulating Hsp72 expression in vitro and in vivo. In: International Journal of Oncology. 2005 ; Vol. 27, No. 6. pp. 1527-1533.
@article{c315f5a53fa3403eb9c52605744d8264,
title = "Vitamins K1 and K2 potentiate hyperthermia by down-regulating Hsp72 expression in vitro and in vivo",
abstract = "Hyperthermia is used to treat various malignancies, including esophageal, stomach and rectal cancer. Since hyperthermia alone has produced limited results, much attention has been focused on combining hyperthermia with chemotherapy and on searching for substances able to sensitize tumor cells to hyperthermia-induced damage. Here, we show that vitamins K1 and K2 (VK1, VK2) inhibited the expression of heat-shock protein 72 (Hsp72) but did not affect the constitutive expression of Hsc70 or calnexin in vitro and in vivo. VK, and VK2 sensitized A549 cells to heat-shock induced cell death, while the compounds alone had no effect on cell viability. The suppression of Hsp72 was apparently at the protein level because the mRNA expression of Hsp72 was unchanged. Moreover, the chaperone activity of Hsp72 was compromised after heat-shock when cells were pre-treated with VK 2. The effect of VK2 on Hsp72 suppression, however, was also observed in normal mouse tissue after the mice were subjected to whole-body hyperthermia. To eliminate this side effect, local hyperthermia was performed on tumors in mice. The pre-treatment with VK2 potentiated the effect of local hyperthermia on tumor growth suppression. The findings here that VK1 and VK2 inhibit heat-shock-induced Hsp72 suggest their possible use as an adjuvant for hyperthermia in cancer therapy.",
keywords = "Heat shock, Hsp72, Hyperthermia, Tumor cells, Vitamin K",
author = "Shuji Shimohara and Toru Murakami and Mari Morikawa and Junko Matsuo and Nagayama, {Shin Ichi} and Tsuyoshi Shuto and Suico, {Mary Ann} and Tsukasa Okiyoneda and Isao Yamatsu and Toru Mizushima and Tatsuya Shimasaki and Hirofumi Kai",
year = "2005",
month = "12",
language = "English",
volume = "27",
pages = "1527--1533",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "6",

}

TY - JOUR

T1 - Vitamins K1 and K2 potentiate hyperthermia by down-regulating Hsp72 expression in vitro and in vivo

AU - Shimohara, Shuji

AU - Murakami, Toru

AU - Morikawa, Mari

AU - Matsuo, Junko

AU - Nagayama, Shin Ichi

AU - Shuto, Tsuyoshi

AU - Suico, Mary Ann

AU - Okiyoneda, Tsukasa

AU - Yamatsu, Isao

AU - Mizushima, Toru

AU - Shimasaki, Tatsuya

AU - Kai, Hirofumi

PY - 2005/12

Y1 - 2005/12

N2 - Hyperthermia is used to treat various malignancies, including esophageal, stomach and rectal cancer. Since hyperthermia alone has produced limited results, much attention has been focused on combining hyperthermia with chemotherapy and on searching for substances able to sensitize tumor cells to hyperthermia-induced damage. Here, we show that vitamins K1 and K2 (VK1, VK2) inhibited the expression of heat-shock protein 72 (Hsp72) but did not affect the constitutive expression of Hsc70 or calnexin in vitro and in vivo. VK, and VK2 sensitized A549 cells to heat-shock induced cell death, while the compounds alone had no effect on cell viability. The suppression of Hsp72 was apparently at the protein level because the mRNA expression of Hsp72 was unchanged. Moreover, the chaperone activity of Hsp72 was compromised after heat-shock when cells were pre-treated with VK 2. The effect of VK2 on Hsp72 suppression, however, was also observed in normal mouse tissue after the mice were subjected to whole-body hyperthermia. To eliminate this side effect, local hyperthermia was performed on tumors in mice. The pre-treatment with VK2 potentiated the effect of local hyperthermia on tumor growth suppression. The findings here that VK1 and VK2 inhibit heat-shock-induced Hsp72 suggest their possible use as an adjuvant for hyperthermia in cancer therapy.

AB - Hyperthermia is used to treat various malignancies, including esophageal, stomach and rectal cancer. Since hyperthermia alone has produced limited results, much attention has been focused on combining hyperthermia with chemotherapy and on searching for substances able to sensitize tumor cells to hyperthermia-induced damage. Here, we show that vitamins K1 and K2 (VK1, VK2) inhibited the expression of heat-shock protein 72 (Hsp72) but did not affect the constitutive expression of Hsc70 or calnexin in vitro and in vivo. VK, and VK2 sensitized A549 cells to heat-shock induced cell death, while the compounds alone had no effect on cell viability. The suppression of Hsp72 was apparently at the protein level because the mRNA expression of Hsp72 was unchanged. Moreover, the chaperone activity of Hsp72 was compromised after heat-shock when cells were pre-treated with VK 2. The effect of VK2 on Hsp72 suppression, however, was also observed in normal mouse tissue after the mice were subjected to whole-body hyperthermia. To eliminate this side effect, local hyperthermia was performed on tumors in mice. The pre-treatment with VK2 potentiated the effect of local hyperthermia on tumor growth suppression. The findings here that VK1 and VK2 inhibit heat-shock-induced Hsp72 suggest their possible use as an adjuvant for hyperthermia in cancer therapy.

KW - Heat shock

KW - Hsp72

KW - Hyperthermia

KW - Tumor cells

KW - Vitamin K

UR - http://www.scopus.com/inward/record.url?scp=33644826490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644826490&partnerID=8YFLogxK

M3 - Article

C2 - 16273208

AN - SCOPUS:33644826490

VL - 27

SP - 1527

EP - 1533

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 6

ER -